We are live on ! Find out more
CI

Chartist Inc Portfolio holdings

AUM $139M
This Fund
S&P 500
This Quarter Est. Return
-12.89%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$16.3M
AUM Growth
-$191M
Cap. Flow
-$188M
Cap. Flow %
-1,154.68%
Top 10 Hldgs %
96.5%
Holding
39
New
Increased
1
Reduced
11
Closed
27

Top Buys

Rank Stock Value
1
AXDX
Accelerate Diagnostics
AXDX
+$216

Sector Composition

Rank Sector Weight
1 Materials 35.83%
2 Healthcare 2.24%
3 Consumer Discretionary 1.38%
4 Communication Services 0%
5 Consumer Staples 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IYM icon
26
iShares US Basic Materials ETF
IYM
$1.12B
-57,536
Closed -$4.67M
IYT icon
27
iShares US Transportation ETF
IYT
$2.33B
-177,736
Closed -$6.49M
JPC icon
28
Nuveen Preferred & Income Opportunities Fund
JPC
$2.93B
-12,500
Closed -$280K
LEN icon
29
Lennar Class A
LEN
$20B
-43,413
Closed -$2.1M
TGT icon
30
Target
TGT
$63.4B
-20,408
Closed -$1.69M
TJX icon
31
TJX Companies
TJX
$172B
-60,660
Closed -$2.02M
VB icon
32
Vanguard Small-Cap ETF
VB
$79.2B
-48,562
Closed -$5.93M
VDE icon
33
Vanguard Energy ETF
VDE
$9.8B
-41,536
Closed -$4.4M
STI
34
DELISTED
SunTrust Banks, Inc.
STI
-45,388
Closed -$1.98M
TFCFA
35
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
-60,497
Closed -$1.99M
LNKD
36
DELISTED
LinkedIn Corporation
LNKD
-10,499
Closed -$2.17M
NWSA
37
DELISTED
NEWS CORPORATION CL-A
NWSA
-13,756
Closed -$202K
AGN
38
DELISTED
Allergan Inc
AGN
-15,248
Closed -$4.69M

Similar funds

Chartist Inc's Q3 2015 Portfolio in Review

As of Q3 2015, Chartist Inc held 39 positions worth $16.3M, down 92% from $207M the previous quarter. Its ten largest holdings account for 97% of the portfolio.

Chartist Inc withdrew a net $188M in Q3 2015, closing 27 positions and reducing 11 holdings. Its most notable exit was iShares Biotechnology ETF, an estimated $12.6M position sold in full.

By sector, the portfolio is most concentrated in Materials at 36% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Chartist Inc added an estimated $216 to Accelerate Diagnostics.

  • Chartist Inc added most to Accelerate Diagnostics in Q3 2015, an estimated $216 increase.
  • Chartist Inc's biggest Q3 2015 reduction was Sherwin-Williams, cutting an estimated $46.6M.
  • Chartist Inc fully exited iShares Biotechnology ETF in Q3 2015, selling an estimated $12.6M.
  • Chartist Inc's ten largest holdings make up 97% of its $16.3M portfolio in Q3 2015.
  • Chartist Inc opened 0 new positions and closed 27 in Q3 2015.
  • Chartist Inc's portfolio value fell 92% quarter-over-quarter to $16.3M.

Based on Chartist Inc's 13F filing for Q3 2015, filed 16 Oct 2015.